Ratios of IGF-I, IGF binding protein-3, and prostate-specific antigen in prostate cancer detection

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 12, 2001, Pages 5745-5748

  Stattin, P ^a   Stenman, U H ^a   Riboli, E ^a   Hallmans, G ^a   Kaaks, R ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HORMONE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 0035217580     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.12.8064     Document Type: Article

References (17)

1. Prostate specific antigen: A decade of discovery-what we have learned and where we are going
2. Prostate-specific antigen
3. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
4. Prostate-specific antigen and other prostate cancer markers
5. Insulin-like growth factor 1 (IGF-1) IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection
6. Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
7. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer
8. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
9. Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer
10. Prostate-specific antigen screening for prostate cancer: Issues involving test validity
11. Role of the insulin-like growth factor family in cancer development and progression
12. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
13. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
14. Insulin-like growth factor 1 is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen
15. Insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 in the detection of prostate cancer in patients undergoing prostate biopsy
16. Prostate cancer screening
17. Levels of insulin-like growth factor 1 (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence